353 related articles for article (PubMed ID: 16306329)
1. Interleukin-6 and diabetes: the good, the bad, or the indifferent?
Kristiansen OP; Mandrup-Poulsen T
Diabetes; 2005 Dec; 54 Suppl 2():S114-24. PubMed ID: 16306329
[TBL] [Abstract][Full Text] [Related]
2. Association between interleukin-6 polymorphism and age-at-onset of type 1 diabetes. Epistatic influences of the tumor necrosis factor-alpha and interleukin-1beta polymorphisms.
Hermann C; Krikovszky D; Füst G; Kovács M; Körner A; Szabó A; Vannay A; Madácsy L
Eur Cytokine Netw; 2005 Dec; 16(4):277-81. PubMed ID: 16464741
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.
Cnop M; Welsh N; Jonas JC; Jörns A; Lenzen S; Eizirik DL
Diabetes; 2005 Dec; 54 Suppl 2():S97-107. PubMed ID: 16306347
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitous interleukin-6: a time for reappraisal.
Fisman EZ; Tenenbaum A
Cardiovasc Diabetol; 2010 Oct; 9():62. PubMed ID: 20937099
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus.
Tsiavou A; Hatziagelaki E; Chaidaroglou A; Manginas A; Koniavitou K; Degiannis D; Raptis SA
J Clin Immunol; 2004 Nov; 24(6):591-9. PubMed ID: 15622443
[TBL] [Abstract][Full Text] [Related]
6. Role of pancreatic β-cell death and cell death-associated inflammation in diabetes.
Lee MS; Kim KA; Kim HS
Curr Mol Med; 2012 Dec; 12(10):1297-310. PubMed ID: 22834831
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
8. The Emerging Roles of IL-36, IL-37, and IL-38 in Diabetes Mellitus and its Complications.
Huang G; Li M; Tian X; Jin Q; Mao Y; Li Y
Endocr Metab Immune Disord Drug Targets; 2022; 22(10):997-1008. PubMed ID: 35049442
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 6 protects pancreatic β cells from apoptosis by stimulation of autophagy.
Linnemann AK; Blumer J; Marasco MR; Battiola TJ; Umhoefer HM; Han JY; Lamming DW; Davis DB
FASEB J; 2017 Sep; 31(9):4140-4152. PubMed ID: 28592636
[TBL] [Abstract][Full Text] [Related]
10. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus.
Akash MS; Rehman K; Chen S
J Cell Biochem; 2013 Mar; 114(3):525-31. PubMed ID: 22991242
[TBL] [Abstract][Full Text] [Related]
11. IL-6 is present in beta and alpha cells in human pancreatic islets: Expression is reduced in subjects with type 1 diabetes.
Rajendran S; Anquetil F; Quesada-Masachs E; Graef M; Gonzalez N; McArdle S; Chu T; Krogvold L; Dahl-Jørgensen K; von Herrath M
Clin Immunol; 2020 Feb; 211():108320. PubMed ID: 31809899
[TBL] [Abstract][Full Text] [Related]
12. Exercise increases pancreatic β-cell viability in a model of type 1 diabetes through IL-6 signaling.
Paula FM; Leite NC; Vanzela EC; Kurauti MA; Freitas-Dias R; Carneiro EM; Boschero AC; Zoppi CC
FASEB J; 2015 May; 29(5):1805-16. PubMed ID: 25609426
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease.
Pedersen BK
Eur J Clin Invest; 2017 Aug; 47(8):600-611. PubMed ID: 28722106
[TBL] [Abstract][Full Text] [Related]
14. XOMA 052, an anti-IL-1β monoclonal antibody, prevents IL-1β-mediated insulin resistance in 3T3-L1 adipocytes.
Handa M; Vanegas S; Maddux BA; Mendoza N; Zhu S; Goldfine ID; Mirza AM
Obesity (Silver Spring); 2013 Feb; 21(2):306-9. PubMed ID: 23401297
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes.
Maedler K; Dharmadhikari G; Schumann DM; Størling J
Handb Exp Pharmacol; 2011; (203):257-78. PubMed ID: 21484575
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes.
Ladefoged M; Buschard K; Hansen AM
APMIS; 2013 Jun; 121(6):531-8. PubMed ID: 23134512
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes.
Banerjee M; Saxena M
Clin Chim Acta; 2012 Aug; 413(15-16):1163-70. PubMed ID: 22521751
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycemia Affects the Expression of Inflammatory Genes in Peripheral Blood Mononuclear Cells of Patients with Type 2 Diabetes.
Akbari M; Hassan-Zadeh V
Immunol Invest; 2018 Oct; 47(7):654-665. PubMed ID: 29851525
[TBL] [Abstract][Full Text] [Related]
19. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
Donath MY; Böni-Schnetzler M; Ellingsgaard H; Ehses JA
Physiology (Bethesda); 2009 Dec; 24():325-31. PubMed ID: 19996363
[TBL] [Abstract][Full Text] [Related]
20. Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients.
Ruscitti P; Cipriani P; Di Benedetto P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Alvaro S; Triolo G; Giacomelli R
Clin Exp Immunol; 2015 Oct; 182(1):35-44. PubMed ID: 26095630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
